American Academy of Allergy Asthma & Immunology: Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies
February 26, 2024
February 26, 2024
WASHINGTON, Feb. 26 (TNSres) -- The American Academy of Allergy Asthma and Immunology issued the following news release on Feb. 25, 2024:
* * *
Study highlights a valuable option for safe and effective food allergy treatment.
* * *
Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annua . . .
* * *
Study highlights a valuable option for safe and effective food allergy treatment.
* * *
Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annua . . .